Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Carcinoma, Endometrioid 1Advanced Non-small Cell Lung Cancer 1

Interventions

tislelizumab 1pembrolizumab 1osimertinib 1aflutinib 1Rosuvastatin Calcium 1RO5126766 1Midazolam 1Food 1Esomeprazole 1Drug Therapy 1Docetaxel 1Dabigatran 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Non-small Cell Lung Cancer × RO5126766 × Clear all
NCT03681483 2024-07-10

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
15 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡